Paliperidone for Impulsivity in Borderline Personality Disorder

Evidence for Paliperidone in BPD

Dialectical Behavior Therapy (DBT) is the most effective treatment for BPD and should be initiated first, as it specifically targets impulsivity, emotion regulation, and distress tolerance, with moderate to large statistically significant effects in reducing both suicidal and non-suicidal self-directed violence 1
DBT typically involves weekly individual therapy combined with weekly group skills training over one year, and has demonstrated effectiveness in reducing impulsivity 1

The American Academy of Child and Adolescent Psychiatry recommends that medication should only target specific symptom dimensions, and paliperidone, like other antipsychotics, primarily addresses cognitive-perceptual symptoms and impulsive-behavioral dyscontrol 3
Avoid benzodiazepines for impulsivity, as they may increase disinhibition in BPD patients, according to Praxis Medical Insights 2

Paliperidone should be reserved for patients who pose risk of injury to self or others due to severe impulsivity, are at risk of losing access to important services due to behavioral dyscontrol, or have failed or cannot access adequate psychotherapy, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 3
Paliperidone should never substitute for appropriate psychotherapeutic services, which remain the cornerstone of BPD treatment, according to both the Journal of the American Academy of Child and Adolescent Psychiatry and Praxis Medical Insights 1, 3